An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-7547
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran ; volume:18 ; number:1 ; day:23 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Cost effectiveness and resource allocation ; 18, Heft 1 (23.10.2020), 1-9, 12.2020
- Classification
-
Wirtschaft
- Creator
-
Moradi, Najmeh
Woldemichael, Abraha
Malekian, Parisa
Rotvandi, Delnia Moradi
Rezaei, Satar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12962-020-00241-9
- URN
-
urn:nbn:de:101:1-2020121908301554660901
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moradi, Najmeh
- Woldemichael, Abraha
- Malekian, Parisa
- Rotvandi, Delnia Moradi
- Rezaei, Satar
- SpringerLink (Online service)
Other Objects (12)
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Framework for developing cost-effectiveness analysis threshold: the case of Egypt
Using extraneous information and GMM to estimate threshold parameters in TAR models
Noninvasive method to estimate anaerobic threshold in individuals with type 2 diabetes
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review
Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US
Daylight saving time transitions and hospital treatments due to accidents or manic episodes
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
A simple algorithm to estimate genetic variance in an animal threshold model using Bayesian inference
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Framework for developing cost-effectiveness analysis threshold: the case of Egypt
Using extraneous information and GMM to estimate threshold parameters in TAR models
Noninvasive method to estimate anaerobic threshold in individuals with type 2 diabetes
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review
Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US
Daylight saving time transitions and hospital treatments due to accidents or manic episodes
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
A simple algorithm to estimate genetic variance in an animal threshold model using Bayesian inference
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Framework for developing cost-effectiveness analysis threshold: the case of Egypt
Using extraneous information and GMM to estimate threshold parameters in TAR models
Noninvasive method to estimate anaerobic threshold in individuals with type 2 diabetes
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review
Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US
Daylight saving time transitions and hospital treatments due to accidents or manic episodes
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan